Fibrinolytic mechanism, biochemistry, and preclinical pharmacology of recombinant prourokinase (Q41082452)

26 September 2017

1 reference

title

Fibrinolytic mechanism, biochemistry, and preclinical pharmacology of recombinant prourokinase (English)

1 reference

26 September 2017

R B Credo

1

1 reference

26 September 2017

S E Burke

series ordinal

2

1 reference

26 September 2017

publication date

1 November 1995

1 reference

Journal of Vascular and Interventional Radiology

26 September 2017

published in

1 reference

26 September 2017

volume

6

1 reference

26 September 2017

issue

6 Pt 2 Suppl

1 reference

26 September 2017

page(s)

8S-18S

1 reference

New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction. Prourokinase Study Group

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Efficacy and safety of repeated boluses of urokinase in the treatment of deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Thrombolytic intervention in acute thrombotic and embolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Interventional neurovascular techniques for cerebral revascularization in the treatment of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158)

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Activation of plasminogen by tissue activator is increased specifically in the presence of certain soluble fibrin(ogen) fragments

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

High level expression of human proteins in murine hybridoma cells: induction by methotrexate in the absence of gene amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

The human urokinase-plasminogen activator gene and its promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Evolutionary assembly of blood coagulation proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Plasminogen activator from human embryonic kidney cell cultures. Evidence for a proactivator

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Carbohydrate composition and presence of a fucose-protein linkage in recombinant human pro-urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Coronary thrombolysis in dogs with intravenously administered human pro-urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Simple canine model of arterial thrombosis with endothelial injury suitable for investigation of thrombolytic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Composition and susceptibility to thrombolysis of human arterial thrombi and the influence of their age

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Time course of left ventricular function and coronary patency after saruplase vs streptokinase in acute myocardial infarction. The PRIMI Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971242-8

7 January 2021

10.1016/S1051-0443(95)71242-8

Identifiers

DOI

1 reference

release_bg7qgqifmng5rnfad6v7yzu55y

26 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bg7qgqifmng5rnfad6v7yzu55y

24 November 2022

mapped directly with Wikidata item

1 reference